Noah Wolkowicz
he/him/his
Assistant Professor of PsychiatryDownloadHi-Res Photo
About
Copy Link
Titles
Assistant Professor of Psychiatry
Biography
I am a licensed Clinical Psychologist at the VA Connecticut Healthcare System (VACHS) in West Haven and an Assistant Professor of Psychiatry at the Yale School of Medicine. I completed my graduate work at the University of Arkansas in 2021, and my predoctoral internship and postdoctoral fellowship at the VACHS. My research program focuses on developing and evaluating digital health interventions for addictive disorders, as well as identifying risk factors that exacerbate their course or treatment. My clinica work utilizes evidence-based treatments, such as cognitive behavioral therapy, motivational enhancement, and written exposure therapy, for treating substance use disorders and commonly co-occurring conditions like PTSD and chronic pain. I am the recipient of a 5-year VA Rehabilitation R&D Career Development Award to develop a smartphone-based mobile application to support Veterans receiving medication treatment for opioid use disorder (Project Award ID: 1IK2RX005015-01A1).
Last Updated on January 05, 2025.
Education & Training
- Postdoctoral Fellow
- VISN 1 Mental Illness Research, Education, and Clinical Center (2024)
- PhD
- University of Arkansas, Psychology (2021)
- Predoctoral Intern
- VA Connecticut Healthcare System (2021)
- MS
- University of South Carolina Aiken, Psychology (2016)
- BA
- Roger Williams University, Psychology (2014)
Research
Copy Link
Overview
Dr. Noah R. Wolkowicz is a licensed Psychologist at the VA Connecticut Healthcare System (VACHS) in West Haven and an Assistant Professor of Psychiatry at the Yale School of Medicine. He completed his doctoral internship at the VACHS Addiction Track and his PhD in Clinical Psychology at the University of Arkansas. His research program focuses on developing and evaluating digital health interventions for addictive disorders, as well as identifying risk factors that exacerbate their course or treatment. Dr. Wolkowicz also has a background in multilevel modeling, a statistical technique well-suited for examining interindividual differences in intraindividual change (e.g., treatment response), and experience working with the VHA’s Corporate Data Warehouse. He is currently the recipient of a 5-year VA Rehabilitation R&D Career Development Award to develop a smartphone-based mobile application to support Veterans receiving medication treatment for opioid use disorder (Award ID: 1IK2RX005015-01A1).
ORCID
0000-0002-4443-2265
Research at a Glance
Yale Co-Authors
Frequent collaborators of Noah Wolkowicz's published research.
Publications Timeline
A big-picture view of Noah Wolkowicz's research output by year.
Mehmet Sofuoglu, MD, PhD
R. Ross MacLean, PhD
Brian Pittman
Joao P. De Aquino, MD
Alicia Heapy, PhD
Julia Meyerovich
28Publications
207Citations
Publications
2025
Prevalence & Characteristics of E-Cigarette and Nicotine Pouch Use Among United States Military Veteran Smokers
Wolkowicz N, Schwartz E, Hefner K, Sofuoglu M. Prevalence & Characteristics of E-Cigarette and Nicotine Pouch Use Among United States Military Veteran Smokers. Military Medicine 2025, usaf521. PMID: 41231681, DOI: 10.1093/milmed/usaf521.Peer-Reviewed Original ResearchAltmetricConceptsAlternative nicotine productsVeterans Health AdministrationU.S. military veteransE-cigarettesDual usersCombustible cigarettesMilitary veteransMental health/substance use disordersPast-year quit attemptsPacks-per-dayCharacteristics of e-cigarettesNicotine productsHeightened health risksE-cigarette usePast-month cigarette useE-cigarette usersPast-month useVeteran dataVeteran smokersNP usersNon-HispanicPaper-and-pencil surveyCurrent smokersHealth AdministrationVeterans' beliefsU.S. Military Veteran Perspectives on Barriers and Facilitators to Medication Treatment for Opioid Use Disorder
Wolkowicz N, Musket C, Sofuoglu M, Reilly E, MacLean R, Portnoy G. U.S. Military Veteran Perspectives on Barriers and Facilitators to Medication Treatment for Opioid Use Disorder. Substance Use & Misuse 2025, ahead-of-print: 1-13. PMID: 41194384, DOI: 10.1080/10826084.2025.2580518.Peer-Reviewed Original ResearchConceptsOpioid use disorderUse disorderSocial-ecological levelsSocial-ecological frameworkVeterans' perspectivesMilitary veteransIntervention effortsIndividual semi-structured interviewsVeteransSemi-structured interviewsPublic health concernDisordersMedical treatmentMOUD careOpioidPatient autonomyMOUDQualitative studySimplification of administrative proceduresCollaborative decision-makingCode definitionsHealth concernBarriers/facilitatorsOpioid crisisSocietal levelAssessment of Two Online Interventions for Veterans With Chronic Pain: Protocol for a Randomized Controlled Efficacy Trial
Reilly E, Grigorian H, Heapy A, Etingen B, Kelly M, Wolkowicz N, Girouard C, Hogan T, Bernice K, Bickmore T. Assessment of Two Online Interventions for Veterans With Chronic Pain: Protocol for a Randomized Controlled Efficacy Trial. JMIR Research Protocols 2025, 14: e70601. PMID: 40802968, PMCID: PMC12391840, DOI: 10.2196/70601.Peer-Reviewed Original ResearchAltmetricMeSH Keywords and ConceptsConceptsPain-related functioningINTERNATIONAL REGISTERED REPORT IDENTIFIERQuality of lifeOnline interventionPain schoolChronic painQualitative exit interviewsChronic musculoskeletal painRandomized controlled efficacy trialAt-home programsPain-related outcomesRandomized controlled superiority trialNegative pain-related outcomesPain treatment optionsActive control groupRandomized Controlled TrialsIntervention's usabilityPain programMindfulness-based interventionsMusculoskeletal painControlled efficacy trialExit interviewsPain severityUS veteransDaily functioningCognitive bias modification for individuals with opioid use disorder and chronic pain did not predict changes in clinical outcomes.
Wolkowicz N, Pittman B, Schrader S, Wesolowicz D, Sofuoglu M, Heapy A, MacLean R. Cognitive bias modification for individuals with opioid use disorder and chronic pain did not predict changes in clinical outcomes. Journal Of Studies On Alcohol And Drugs 2025 PMID: 40536409, PMCID: PMC12569794, DOI: 10.15288/jsad.25-00057.Peer-Reviewed Original ResearchConceptsCognitive bias modificationAttentional biasOpioid cravingBias modificationCBM effectsSubstance use disordersPain severityChronic painClinical outcomesAddiction severityOpioid use disorderUse disorderNaturalistic settingsNeutral-cueOpioid withdrawalPain cuesCravingDiverse sampleSalient outcomesSubstance typePreliminary effectivenessPrimary clinical outcomePain catastrophizingModerate painPain intensityPreliminary Feasibility, Acceptability and Referral Efficacy of a Drop-In Dialectical Behavior Therapy (DBT) Skills Group to Promote Enrollment in Standard DBT Skills Group
Aunon F, Carretta R, Lovell J, Wolkowicz N, Decker S. Preliminary Feasibility, Acceptability and Referral Efficacy of a Drop-In Dialectical Behavior Therapy (DBT) Skills Group to Promote Enrollment in Standard DBT Skills Group. Cognitive And Behavioral Practice 2025, 32: 244-257. DOI: 10.1016/j.cbpra.2024.01.003.Peer-Reviewed Original ResearchAltmetricConceptsDBT skills groupSkill groupsDialectical Behaviour Therapy Skills GroupDialectical behavior therapyEvidence-based treatmentsDBT skillsBehavioral therapyMindfulness practiceTreatment readinessAmbivalent clientsPretreatment interventionClientsPreliminary feasibilitySkillsMindfulnessAcceptanceSessionsEfficacyParticipantsPretreatmentReferralGroupInterventionAcceptance and Commitment Therapy for Posttraumatic Stress Disorder
Kelly M, Grigorian H, Wolkowicz N, Zegel M. Acceptance and Commitment Therapy for Posttraumatic Stress Disorder. Psychiatric Clinics Of North America 2025, 48: 551-562. PMID: 40738533, DOI: 10.1016/j.psc.2025.02.009.Peer-Reviewed Original ResearchCitationsMeSH Keywords and ConceptsConceptsPosttraumatic stress disorderEfficacy of ACTStress disorderCommitment TherapyPosttraumatic stress disorder symptomsValues-based livingExperiential avoidancePsychological flexibilityTraumatic experiencesDisordersQuality of lifeClinical trialsFuture researchMindfulnessAvoidanceAcceptanceSymptomsTrialsPeopleActEfficacyTraumaSwitching from menthol to non-menthol cigarettes does not impact acute responses to intravenous nicotine
Wolkowicz N, Parida S, Gueorguieva R, Sofuoglu M. Switching from menthol to non-menthol cigarettes does not impact acute responses to intravenous nicotine. Pharmacology Biochemistry And Behavior 2025, 249: 173985. PMID: 40010441, PMCID: PMC11932434, DOI: 10.1016/j.pbb.2025.173985.Peer-Reviewed Original ResearchMeSH Keywords and ConceptsConceptsContinuous Performance TestResponse to nicotineNicotine infusionNon-menthol cigarettesAcute responses to nicotineExperimental sessionsIntravenous nicotine infusionsNicotine metabolite ratioSmoking conditionsDaily cigarette smokingTobacco withdrawalWithdrawal severitySmoking urgesNicotine administrationCigarette consumptionIntravenous nicotineSmoking menthol cigarettesDrug effectsNicotineReduce cigarette consumptionHeart rate responseMetabolite ratiosBlood levelsPrimary outcomeInfusion periodTo Adopt or Adapt: A Scoping Review of Dialectical Behaviour Therapy With Patients With Minoritised Identity Constructs
Aunon F, Ingram P, Wolkowicz N, Martino S, Kacos H, Spana E, Honsberger M, Rielage J, Doran N, Carretta R, Ridley J, Giovannelli T, Bannister J, Merians A, Howell B, Demirelli S, Smith J, Decker S. To Adopt or Adapt: A Scoping Review of Dialectical Behaviour Therapy With Patients With Minoritised Identity Constructs. Counselling And Psychotherapy Research 2025, 25 DOI: 10.1002/capr.70000.Peer-Reviewed Original ResearchCitationsConceptsDialectical behavior therapyEvidence-based psychological interventionsBehavioral therapyReducing suicidal behaviourSuicidal behaviorPsychological interventionsWhite samplesImplementation science frameworkPatient populationModifications-EnhancedArticles of studiesImplementation outcomesScoping ReviewAdult patient populationScience FrameworkWestern contextsPsycINFOClinical administrationDocument adaptationPRINCIPLE FINDINGSContextT108 A Qualitative Investigation of Veterans’ Perceived Barriers to Medication Treatment for Opioid Use Disorder
Wolkowicz N, Musket C, Sofuoglu M, Reilly E, MacLean R, Portnoy G. T108 A Qualitative Investigation of Veterans’ Perceived Barriers to Medication Treatment for Opioid Use Disorder. Drug And Alcohol Dependence 2025, 267: 111876. DOI: 10.1016/j.drugalcdep.2024.111876.Peer-Reviewed Original Research
2024
The Importance of Treatment Modality in Veterans with Opioid Use Disorder: Implications for Virtual Care
Meshberg-Cohen S, Schnakenberg Martin A, Wolkowicz N, Gross G, DeViva J. The Importance of Treatment Modality in Veterans with Opioid Use Disorder: Implications for Virtual Care. Community Mental Health Journal 2024, 61: 899-906. PMID: 39704754, DOI: 10.1007/s10597-024-01428-7.Peer-Reviewed Original ResearchConceptsAlcohol use disorderPsychiatric emergency roomUse disorderPsychotic disordersOpioid use disorderComorbid alcohol use disorderTreatment engagementPsychiatric comorbiditiesTelehealth transitionAddiction treatmentTreatment utilizationIllness severityTreatment modalitiesDisordersVeteransOpioidVirtual treatmentMOUDAddictionIn-personFrequent in-person visitsEmergency roomTreatment recordsDemographic featuresIllness
Get In Touch
Copy Link